LifePoint Hospitals could reach its USD 78.9 resistance.

The company’s fundamentals are still strong. Sales are up + 13.5% for this year. Analysts from Thomson Reuters consensus have revised largely upward their EPS estimates.

Technically, the security is in an uptrend on all time scales and it is supported by moving averages. The bullish trend will not be stopped until prices are above the USD 74.05 short term pivot point. This trend should allow the stock to reach its USD 78.9 short term resistance, which will be the first target price.

According to both technical and fundamental elements, it seems opportune to take a long position at the current price. A stop loss will be placed under the USD 74.05 short term support to avoid a downtrend.